Enhancing Organ Donation Consent Rates in the Pediatric Intensive Care Unit: A Proposed Guideline

Added is the document where I attempted to write with chat GPT the paper. Please re-write the paper without the use of AI (because of AI detectors) and check or even add references as needed. It is very imposrtant that it has zero plagiarism and use of AI. 

The paper should follor the guidelines of Frontiers journal

Frontiersin.org Guidelines

The title should be concise, omitting terms that are implicit and, where possible, be a statement of the main result or conclusion presented in the manuscript. Abbreviations should be avoided within the title.

Witty or creative titles are welcome, but only if relevant and within measure. Consider if a title meant to be thought-provoking might be misinterpreted as offensive or alarming. In extreme cases, the editorial office may veto a title and propose an alternative.

Authors should avoid:

• titles that are a mere question without giving the answer

• unambitious titles, for example starting with ‘Towards,’ ‘A description of,’ ‘A characterization of’ or ‘Preliminary study on’

• vague titles, for example starting with ‘Role of’, ‘Link between’, or ‘Effect of’ that do not specify the role, link, or effect

• including terms that are out of place, for example the taxonomic affiliation apart from species name.

For Corrigenda, General Commentaries, and Editorials, the title of your manuscript should have the following format.

• ‘Corrigendum: [Title of original article]’

• General Commentaries:
  ‘Commentary: [Title of original article]’
  ‘Response: Commentary: [Title of original article]’

• ‘Editorial: [Title of Research Topic]’

All names are listed together and separated by commas. Provide exact and correct author names as these will be indexed in official archives. Affiliations should be keyed to the author’s name with superscript numbers and be listed as follows:

• Laboratory, Institute, Department, Organization, City, State abbreviation (only for United States, Canada, and Australia), and Country (without detailed address information such as city zip codes or street names).

Example: Max Maximus1
1 Department of Excellence, International University of Science, New York, NY, United States.

Correspondence

The corresponding author(s) should be marked with an asterisk in the author list. Provide the exact contact email address of the corresponding author(s) in a separate section.

Example: Max Maximus*
[email protected]

If any authors wish to include a change of address, list the present address(es) below the correspondence details using a unique superscript symbol keyed to the author(s) in the author list.

Equal contributions

The authors who have contributed equally should be marked with a symbol (†) in the author list of the doc/latex and pdf files of the manuscript uploaded at submission.

Please use the appropriate standard statement(s) to indicate equal contributions:

• Equal contribution: These authors contributed equally to this work

• First authorship: These authors share first authorship

• Senior authorship: These authors share senior authorship

• Last authorship: These authors share last authorship

• Equal contribution and first authorship: These authors contributed equally to this work and share first authorship

• Equal contribution and senior authorship: These authors contributed equally to this work and share senior authorship

• Equal contribution and last authorship: These authors contributed equally to this work and share last authorship

Example: Max Maximus 1†, John Smith2† and Barbara Smith1
†These authors contributed equally to this work and share first authorship

Consortium/group authorship should be listed in the manuscript with the other author(s).

In cases where authorship is retained by the consortium/group, the consortium/group should be listed as an author separated by a comma or ‘and’. The consortium/group name will appear in the author list, in the citation, and in the copyright. If provided, the consortium/group members will be listed in a separate section at the end of the article.

For the collaborators of the consortium/group to be indexed in PubMed, they do not have to be inserted in the Frontiers submission system individually. However, in the manuscript itself, provide a section with the name of the consortium/group as the heading followed by the list of collaborators, so they can be tagged accordingly and indexed properly.

Example: John Smith, Barbara Smith and The Collaborative Working Group.

In cases where work is presented by the author(s) on behalf of a consortium/group, it should be included in the author list separated with the wording ‘for’ or ‘on behalf of.’ The consortium/group will not retain authorship and will only appear in the author list.

Example: John Smith and Barbara Smith on behalf of The Collaborative Working Group.

These guidelines cover acceptable uses of generative AI technologies such as Large Language Models (ChatGPT, Jasper) and text-to-image generators (DALL-E 2, Midjourney, Stable Diffusion) in the writing or editing of manuscripts submitted to Frontiers.

AI use by authors

Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship.

If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use must follow all Frontiers guidelines and policies. Specifically, the author is responsible for checking the factual accuracy of any content created by the generative AI technology. This includes, but is not limited to, any quotes, citations or references. Figures produced by or edited using a generative AI technology must be checked to ensure they accurately reflect the data presented in the manuscript. Authors must also check that any written or visual content produced by or edited using a generative AI technology is free from plagiarism.

If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, such use must be acknowledged in the acknowledgements section of the manuscript and the methods section if applicable. This explanation must list the name, version, model, and source of the generative AI technology.
We encourage authors to upload all input prompts provided to a generative AI technology and outputs received from a generative AI technology in the supplementary files for the manuscript.

As a primary goal, the abstract should make the general significance and conceptual advance of the work clearly accessible to a broad readership. The abstract should be no longer than a single paragraph and should be structured, for example, according to the IMRAD format. For the specific structure of the abstract, authors should follow the requirements of the article type or journal to which they’re submitting. Minimize the use of abbreviations and do not cite references, figures or tables.

For clinical trial articles, please include the unique identifier and the URL of the publicly-accessible website on which the trial is registered.

All article types require a minimum of five and a maximum of eight keywords.

The entire document should be single-spaced and must contain page and line numbers in order to facilitate the review process. The manuscript should be written using either Word or LaTeX. See above for templates.

The use of abbreviations should be kept to a minimum. Non-standard abbreviations should be avoided unless they appear at least four times, and must be defined upon first use in the main text. Consider also giving a list of non-standard abbreviations at the end, immediately before the acknowledgments.

Equations should be inserted in editable format from the equation editor.

Italicize gene symbols and use the approved gene nomenclature where it is available. For human genes, please refer to the HUGO Gene Nomenclature Committee (HGNC). New symbols for human genes should be submitted to the HGNC here. Common alternative gene aliases may also be reported, but should not be used alone in place of the HGNC symbol. Nomenclature committees for other species are listed here. Protein products are not italicized.

We encourage the use of Standard International Units in all manuscripts.

Chemical compounds and biomolecules should be referred to using systematic nomenclature, preferably using the recommendations by the International Union of Pure and Applied Chemistry (IUPAC).

Astronomical objects should be referred to using the nomenclature given by the International Astronomical Union (IAU) provided here.

Life Science Identifiers (LSIDs) for ZOOBANK registered names or nomenclatural acts should be listed in the manuscript before the keywords. An LSID is represented as a uniform resource name (URN) with the following format: urn:lsid:::[:]

For more information on LSIDs please see the ‘Code’ section of our policies and publication ethics.

The manuscript is organized by headings and subheadings. The section headings should be those appropriate for your field and the research itself. You may insert up to 5 heading levels into your manuscript (i.e.,: 3.2.2.1.2 Heading Title).

For Original Research articles, it is recommended to organize your manuscript in the following sections or their equivalents for your field.

Introduction
Succinct, with no subheadings.

Materials and methods
This section may be divided by subheadings and should contain sufficient detail so that when read in conjunction with cited references, all procedures can be repeated. For experiments reporting results on animal or human subject research, an ethics approval statement should be included in this section (for further information, see the ‘Bioethics’ section of our policies and publication ethics.)

Results
This section may be divided by subheadings. Footnotes should not be used and must be transferred to the main text.

Discussion
This section may be divided by subheadings. Discussions should cover the key findings of the study: discuss any prior research related to the subject to place the novelty of the discovery in the appropriate context, discuss the potential shortcomings and limitations on their interpretations, discuss their integration into the current understanding of the problem and how this advances the current views, speculate on the future direction of the research, and freely postulate theories that could be tested in the future.

For further information, please check the descriptions defined in the journal’s ‘Article types’ page, in the ‘For authors’ menu on every journal page.

This is a short text to acknowledge the contributions of specific colleagues, institutions, or agencies that aided the efforts of the authors. Should the content of the manuscript have previously appeared online, such as in a thesis or preprint, this should be mentioned here, in addition to listing the source within the reference list.

When you submit your manuscript, you will be required to summarize in 200 words your manuscript’s scope and its relevance to the journal and/or specialty section you’re submitting to. The aim is to convey to editors and reviewers how the contents of your manuscript fit within the selected journal’s scope.

This statement will not be published with your article if it is accepted for publication. The information will be used during the initial validation and review processes to assess whether the manuscript is a suitable fit for the chosen journal and specialty.

We encourage you to consider carefully where to submit your manuscript, as submissions to an unsuitable journal or specialty will result in delays and increase the likelihood of manuscript rejection.

If you are submitting to a Research Topic, please also clarify how your submission is suited to the specific topic.

All figures, tables, and images will be published under a Creative Commons CC-BY license, and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, follow any citation instructions requested by third-party rights holders, and cover any supplementary charges.

For additional information, please see the ‘Image manipulation’ section of our policies and publication ethics.

Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.

For figures with more than one panel, panels should be clearly indicated using labels (A), (B), (C), (D), etc. However, do not embed the part labels over any part of the image, these labels will be replaced during typesetting according to Frontiers’ journal style. For graphs, there must be a self-explanatory label (including units) along each axis.

For LaTeX files, figures should be included in the provided PDF. In case of acceptance, our production office might require high-resolution files of the figures included in the manuscript in EPS, JPEG or TIF/TIFF format.

To upload more than one figure at a time, save the figures (labeled in order of appearance in the manuscript) in a zip file and upload them as ‘Supplementary Material Presentation.’

Please note that figures not in accordance with the guidelines will cause substantial delay during the production process

References:

Submissions to Frontiers must be grounded in relevant and up to date peer-reviewed, academic research, and this should be reflected in the accompanying reference lists.

Authors are welcome to use online referencing tools in preparation of their manuscript. Some useful resources include RefMe, Zotero, and Mendeley.

• The citation of non-academic and non-peer-reviewed sources (e.g. blog posts, website content), as well as anonymous sources or commercial websites should be avoided or kept to a minimum

• Authors should avoid citing content that is not directly relevant to the scope of the article and the journal

• Reference lists should reflect the current status of knowledge in the field, avoid bias, and not include a high proportion of citations to the same authors or sources, school of thought, etc.

• The length of the reference list should be appropriate depending on the article type, covering the relevant literature through sufficient referencing

• Authors should ensure that references are accurate, that all links are accessible, and that the citations/references adhere to the reference styles outlined below

Frontiers’ journals use one of two reference styles, either Harvard (author-date) or Vancouver (numbered). These formats should be adhered to for the in-text citations and the reference lists. Please check our help center to find the correct style for the journal to which you’re submitting.

• All citations of published works in the text, figures, or tables must be in the reference list and vice-versa.

• The names of the first six authors followed by et al. and the DOI (when available) should be provided.

• Given names of authors should be abbreviated to initials (e.g. Smith, J., Lewis, C.S., etc.).

• The reference list should only include articles that are published or accepted.

• Unpublished data, submitted manuscripts, or personal communications should be cited within the text only, for article types that allow such inclusions. Where additional details are available, these will be included as footnotes.

• For accepted but unpublished works use ‘in press’ instead of page numbers.

• Data sets that have been deposited to an online repository should be included in the reference list. Include the version and unique identifier when available.

• Personal communications should be documented by a letter of permission.

• Website URLs should be included as footnotes.

• Any inclusion of verbatim text must be contained in quotation marks and should clearly reference the original source.

• Preprints can be cited provided that a DOI or archive URL is available, and the citation clearly mentions that the contribution is a preprint. If a peer-reviewed journal publication for the same preprint exists, the official journal publication is the preferred source. See the preprints section for each reference style below for more information.